Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Psoriatic Arthritis Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Psoriatic Arthritis Drugmarket, defines the market attractiveness level of Psoriatic Arthritis Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Psoriatic Arthritis Drug industry, describes the types of Psoriatic Arthritis Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Psoriatic Arthritis Drug market and the development prospects and opportunities of Psoriatic Arthritis Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Psoriatic Arthritis Drug market in Chapter 13.
By Player:
Pfizer
Abbvie
Amgen
Eli-lilly
Janssen
Celgene
By Type:
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Other
By End-User:
Mild Psoriatic Arthritis
Moderate Psoriatic Arthritis
Severe Psoriatic Arthritis
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Psoriatic Arthritis Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Psoriatic Arthritis Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Psoriatic Arthritis Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Psoriatic Arthritis Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Psoriatic Arthritis Drug Market Analysis and Outlook to 2022
-
7.1 Global Psoriatic Arthritis Drug Consumption (2017-2022)
-
7.2 United States Psoriatic Arthritis Drug Consumption (2017-2022)
-
7.3 Europe Psoriatic Arthritis Drug Consumption (2017-2022)
-
7.4 China Psoriatic Arthritis Drug Consumption (2017-2022)
-
7.5 Japan Psoriatic Arthritis Drug Consumption (2017-2022)
-
7.6 India Psoriatic Arthritis Drug Consumption (2017-2022)
-
7.7 South Korea Psoriatic Arthritis Drug Consumption (2017-2022)
8 Region and Country-wise Psoriatic Arthritis Drug Market Analysis and Outlook to 2028
-
8.1 Global Psoriatic Arthritis Drug Consumption Forecast (2022-2028)
-
8.2 United States Psoriatic Arthritis Drug Consumption Forecast (2022-2028)
-
8.3 Europe Psoriatic Arthritis Drug Consumption Forecast (2022-2028)
-
8.4 China Psoriatic Arthritis Drug Consumption Forecast (2022-2028)
-
8.5 Japan Psoriatic Arthritis Drug Consumption Forecast (2022-2028)
-
8.6 India Psoriatic Arthritis Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Psoriatic Arthritis Drug Consumption Forecast (2022-2028)
9 Global Psoriatic Arthritis Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Psoriatic Arthritis Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global TNF Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global PDE4 Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Interleukin Blockers Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Psoriatic Arthritis Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Mild Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Moderate Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Severe Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
10 Global Psoriatic Arthritis Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Psoriatic Arthritis Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global TNF Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global PDE4 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Interleukin Blockers Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Psoriatic Arthritis Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Mild Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Moderate Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Severe Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
11 Global Psoriatic Arthritis Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Psoriatic Arthritis Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Psoriatic Arthritis Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Psoriatic Arthritis Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Psoriatic Arthritis Drug Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Psoriatic Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Psoriatic Arthritis Drug Product and Service
-
14.2 Abbvie
-
14.2.1 Abbvie Company Details
-
14.2.2 Abbvie Psoriatic Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Abbvie Psoriatic Arthritis Drug Product and Service
-
14.3 Amgen
-
14.3.1 Amgen Company Details
-
14.3.2 Amgen Psoriatic Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Amgen Psoriatic Arthritis Drug Product and Service
-
14.4 Eli-lilly
-
14.4.1 Eli-lilly Company Details
-
14.4.2 Eli-lilly Psoriatic Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eli-lilly Psoriatic Arthritis Drug Product and Service
-
14.5 Janssen
-
14.5.1 Janssen Company Details
-
14.5.2 Janssen Psoriatic Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Janssen Psoriatic Arthritis Drug Product and Service
-
14.6 Celgene
-
14.6.1 Celgene Company Details
-
14.6.2 Celgene Psoriatic Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Celgene Psoriatic Arthritis Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Psoriatic Arthritis Drug
-
Figure Psoriatic Arthritis Drug Picture
-
Table Global Psoriatic Arthritis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Psoriatic Arthritis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Psoriatic Arthritis Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Psoriatic Arthritis Drug Consumption by Country (2017-2022)
-
Figure United States Psoriatic Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Psoriatic Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure China Psoriatic Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Psoriatic Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure India Psoriatic Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Psoriatic Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriatic Arthritis Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Psoriatic Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Psoriatic Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Psoriatic Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Psoriatic Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Psoriatic Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Psoriatic Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TNF Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global PDE4 Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Interleukin Blockers Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Mild Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Moderate Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Severe Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global TNF Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PDE4 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interleukin Blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mild Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Moderate Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Severe Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Psoriatic Arthritis Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Psoriatic Arthritis Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Psoriatic Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Psoriatic Arthritis Drug Product and Service
-
Table Abbvie (Foundation Year, Company Profile and etc.)
-
Table Abbvie Psoriatic Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbvie Psoriatic Arthritis Drug Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Psoriatic Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Psoriatic Arthritis Drug Product and Service
-
Table Eli-lilly (Foundation Year, Company Profile and etc.)
-
Table Eli-lilly Psoriatic Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli-lilly Psoriatic Arthritis Drug Product and Service
-
Table Janssen (Foundation Year, Company Profile and etc.)
-
Table Janssen Psoriatic Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Psoriatic Arthritis Drug Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Psoriatic Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Psoriatic Arthritis Drug Product and Service
-
